CN109674945A - The Chinese medicine composition and preparation method thereof of ulcer is cured in a kind of myogenic hemostasia and detumescence analgesic - Google Patents
The Chinese medicine composition and preparation method thereof of ulcer is cured in a kind of myogenic hemostasia and detumescence analgesic Download PDFInfo
- Publication number
- CN109674945A CN109674945A CN201910164989.2A CN201910164989A CN109674945A CN 109674945 A CN109674945 A CN 109674945A CN 201910164989 A CN201910164989 A CN 201910164989A CN 109674945 A CN109674945 A CN 109674945A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- ulcer
- medicine composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Insects & Arthropods (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides the Chinese medicine compositions that ulcer is cured in a kind of analgesic of myogenic hemostasia and detumescence, it is prepared by the bulk pharmaceutical chemicals of following weight proportion: 80~360 parts of the bletilla striata, 80~360 parts of olibanum, 80~360 parts of myrrh, 80~360 parts of catechu, 80~360 parts of Chinese gall, 80~360 parts of the coptis, 80~360 parts of kuh-seng, 80~360 parts of Cortex Phellodendri, 40~180 parts of dragon's blood, 40~180 parts of Pollen Typhae, 40~180 parts of Radix Notoginseng, 40~180 parts of the root of Dahurain angelica, 40~180 parts of Asian puccoon, raw 40~180 parts of Radix Astragali, 20~60 parts of Radix Angelicae Sinensis, 20~60 parts of borneol, 20~60 parts of Radix Glycyrrhizae.The present invention also provides the preparation methods of the Chinese medicine composition.Chinese medicine composition energy myogenic hemostasis provided by the invention, swelling and pain relieving, more ulcer, have exact curative effect especially for ulcer wound surfaces such as bedsores, and easy to use, have stronger practical application value.
Description
Technical field
The present invention relates to the field of Chinese medicines, and in particular to the Chinese medicine composition and its system of ulcer are cured in a kind of myogenic hemostasia and detumescence analgesic
Preparation Method.
Background technique
People are injured unavoidable in carrying out production and living, and the surface of a wound is difficult to heal clinical also more more when operative treatment
See.Meanwhile wound, microorganism infection, tumour, dyshaemia and neurological dysfunction, immunologic dysfunction or congenital skin lack
Damage etc. also easily causes limitation Skin preparation, forms ulcer.The long disunion of the surface of a wound, seriously affects quality of life.Wherein,
Pressure ulcer (referred to as pressure sore, also known as bedsore) is that continuous ischemia, anoxic, nutrition occurs since local organization is pressurized for a long time
It is bad and cause tissue fester downright bad.The problem of pressure ulcer is a universality in rehabilitation, nursing.According to related document report
Road, there are about 60,000 people to die of pressure sore concomitant symptoms every year.It is with a long history but existing that ulcer aspect is cured in the analgesic of traditional Chinese medicine myogenic hemostasia and detumescence
There is not yet being cured the relevant report of the Chinese medicine composition of ulcer about myogenic hemostasia and detumescence of the present invention analgesic in technology.
Summary of the invention
The purpose of the present invention is to provide the Chinese medicine compositions and preparation method thereof that ulcer is cured in a kind of analgesic of myogenic hemostasia and detumescence.
The present invention provides the Chinese medicine compositions that ulcer is cured in a kind of analgesic of myogenic hemostasia and detumescence, it is by following weight proportion
Bulk pharmaceutical chemicals are prepared: 80~360 parts of the bletilla striata, 80~360 parts of olibanum, and 80~360 parts of myrrh, 80~360 parts of catechu, Chinese gall
80~360 parts, 80~360 parts of the coptis, 80~360 parts of kuh-seng, 80~360 parts of Cortex Phellodendri, 40~180 parts of dragon's blood, Pollen Typhae 40~
180 parts, 40~180 parts of Radix Notoginseng, 40~180 parts of the root of Dahurain angelica, 40~180 parts of Asian puccoon, raw 40~180 parts of Radix Astragali, 20~60 parts of Radix Angelicae Sinensis,
20~60 parts of borneol, 20~60 parts of Radix Glycyrrhizae.
Further, aforementioned Chinese medicine composition is prepared by the bulk pharmaceutical chemicals of following weight proportion: 300 parts of the bletilla striata, cream
It is 300 parts fragrant, 300 parts of myrrh, 300 parts of catechu, 300 parts of Chinese gall, 300 parts of the coptis, 300 parts of kuh-seng, 300 parts of Cortex Phellodendri, dragon's blood 150
Part, 150 parts of Pollen Typhae, 150 parts of Radix Notoginseng, 150 parts of the root of Dahurain angelica, 150 parts of Asian puccoon, raw 150 parts of Radix Astragali is 50 parts of Radix Angelicae Sinensis, 50 parts of borneol, sweet
50 parts of grass.
Further, aforementioned Chinese medicine composition is that by the medicinal powder of bulk pharmaceutical chemicals of the weight proportion, the water of bulk pharmaceutical chemicals or have
Solvent extract is active constituent, in addition the preparation that pharmaceutically acceptable auxiliary material is prepared.
Further, the preparation is external preparation.
Further, the external preparation is lotion, plastics, liniment, paste, decoction, powder, ointment, aerosol
Or spray.
The present invention also provides a kind of methods for preparing Chinese medicine composition above-mentioned, it includes the following steps:
A, the raw material of each weight proportion is weighed；
B, raw material directly beaten to powder, or after adding water or organic solvent to extract, pharmaceutically acceptable auxiliary material or auxiliary is added
Property ingredient is prepared.
The present invention also provides Chinese medicine compositions above-mentioned in preparation myogenic hemostasis, swelling and pain relieving, is cured in the drug of ulcer
Purposes.
Further, the drug is the drug of wound healing.
Further, the surface of a wound is ulcer wound surface.
Further, the ulcer wound surface is bedsore.
Myogenic hemostasia and detumescence of the present invention analgesic be cured ulcer Chinese medicine composition be by the bletilla striata, olibanum, myrrh, catechu, Chinese gall,
The coptis, kuh-seng, Cortex Phellodendri, dragon's blood, Pollen Typhae, Radix Notoginseng, the root of Dahurain angelica, Asian puccoon, raw Radix Astragali, Radix Angelicae Sinensis, borneol and Radix Glycyrrhizae composition.
Pollen Typhae is the dry pollen of Typhaceae plant typha orientalis, the turbid cattail of water or congener.
Raw Radix Astragali is that the root of astragalus mongholicus or astragalus membranaceus of leguminous plant shines dry chip and obtains.
Bletilla striata astringing to arrest bleeding, detumescence and promoting granulation in side, olibanum, myrrh detumescence and promoting granulation, removing blood stasis and acesodyne, catechu hygroscopic myogenic are held back
Sore, the coptis, kuh-seng, Cortex Phellodendri, the root of Dahurain angelica, Chinese gall, Asian puccoon removing toxic substances sore, dragon's blood removing blood stasis and relieving pain, hemostasia and promoting granulation, Pollen Typhae, Radix Notoginseng
Dissipating stasis and stanching bleeding, detumescence ding-tong, raw Radix Astragali, Radix Angelicae Sinensis QI invigorating and blood, borneol clearing away heat to and alleviating pain, Radix Glycyrrhizae detoxification sore treatment, coordinating the drug actions of a prescription.All medicines
It shares, plays myogenic hemostasis altogether, swelling and pain relieving, is cured the benefits of ulcer.
Chinese medicine composition energy myogenic hemostasis provided by the invention, swelling and pain relieving, more ulcer, are created especially for ulcer such as bedsores
There is exact curative effect in face, and easy to use, has stronger practical application value.
Obviously, above content according to the present invention, according to the ordinary technical knowledge and customary means of relevant art,
Under the premise of not departing from above-mentioned basic fundamental thought of the invention, the modification, replacement or change of other diversified forms can also be made.
The specific embodiment of form by the following examples remakes further specifically above content of the invention
It is bright.But the range that this should not be interpreted as to the above-mentioned theme of the present invention is only limitted to example below.It is all to be based on above content of the present invention
The technology realized all belongs to the scope of the present invention.
Specific embodiment
The preparation of 1 the traditional chinese medicine composition of the invention of embodiment
(1) raw material: bletilla striata 300g, olibanum 300g, myrrh 300g, catechu 300g, Chinese gall 300g, coptis 300g, kuh-seng
300g, Cortex Phellodendri 300g, dragon's blood 150g, Pollen Typhae 150g, Radix Notoginseng 150g, root of Dahurain angelica 150g, Asian puccoon 150g, raw Radix Astragali 150g, Radix Angelicae Sinensis
50g, borneol 50g, Radix Glycyrrhizae 50g.
(2) preparation method: weighing bulk pharmaceutical chemicals by above-mentioned weight proportion, and bulk pharmaceutical chemicals are broken into thick end, is impregnated with rape oil 5kg thick
End one week, is subsequently placed on fire and is heated to oily rolling, then small fire is decocted slowly to dregs of a decoction zoom Huang Weidu, after medical fluid cooling, filtering
Remove slag, bottling to get.
The preparation of 2 the traditional chinese medicine composition of the invention of embodiment
(1) raw material: bletilla striata 200g, olibanum 200g, myrrh 200g, catechu 200g, Chinese gall 200g, coptis 200g, kuh-seng
200g, Cortex Phellodendri 200g, dragon's blood 100g, Pollen Typhae 100g, Radix Notoginseng 100g, root of Dahurain angelica 100g, Asian puccoon 100g, raw Radix Astragali 100g, Radix Angelicae Sinensis
30g, borneol 30g, Radix Glycyrrhizae 30g.
(2) preparation method: weighing bulk pharmaceutical chemicals by above-mentioned weight proportion, and bulk pharmaceutical chemicals are broken into thick end, is impregnated with rape oil 4kg thick
End one week, is subsequently placed on fire and is heated to oily rolling, then small fire is decocted slowly to dregs of a decoction zoom Huang Weidu, after medical fluid cooling, filtering
Remove slag, bottling to get.
The preparation of 3 the traditional chinese medicine composition of the invention of embodiment
(1) raw material: bletilla striata 100g, olibanum 100g, myrrh 100g, catechu 100g, Chinese gall 100g, coptis 100g, kuh-seng
100g, Cortex Phellodendri 100g, dragon's blood 50g, Pollen Typhae 50g, Radix Notoginseng 50g, root of Dahurain angelica 50g, Asian puccoon 50g, raw Radix Astragali 50g, Radix Angelicae Sinensis 25g, ice
Piece 25g, Radix Glycyrrhizae 25g.
(2) preparation method: weighing bulk pharmaceutical chemicals by above-mentioned weight proportion, and bulk pharmaceutical chemicals are broken into thick end, is impregnated with rape oil 3kg thick
End one week, is subsequently placed on fire and is heated to oily rolling, then small fire is decocted slowly to dregs of a decoction zoom Huang Weidu, after medical fluid cooling, filtering
Remove slag, bottling to get.
Beneficial effects of the present invention are proved below by way of specific clinical test.
The clinical efficacy of 1 the traditional chinese medicine composition of the invention of test example
1, clinical data
Choose the third phase pressure sore i.e. bedsore of either shallow ulcerative stage being hospitalized during in January, 2017~2018 year December in the court
Patient 44, control group and test group are divided into using random packet mode.Wherein control group 22, male 15, female 7, the age
52~90 years old, average (66.7 ± 3.5) year.Test group 22, male 13, female 9, the age 50~92 years old, average (65.24 ±
7.5) year.
1.1 patients are included in standard
Meet the diagnosis mark of bedsore in People's Republic of China's traditional Chinese medicine industry standard Standards for Diagnosis and Curative Effect of Chinese Medical Symptom
Standard, vital sign is steady, patient's informed consent, the person that is ready partner treatment.
1.2 patient's exclusion criterias
Patient and family members refuse partner treatment person；Allergic constitution is known to this medicine ingredient allergy sufferers；Participating in other
The patient of clinical drug trial.
2, therapeutic scheme
2.1 therapeutic agent
Experimental group: the Chinese medicine composition of the preparation of the embodiment of the present invention 1 is given.
Control group: Kangfuxin Liquid is given.
2.2 specific medications are as follows:
While Cure the Primary Disease, Local treatment is given as early as possible.Two groups are all given 0.5% povidone before the treatment
Iodine solution wipes the surface of a wound, is rinsed later with 0.9% sodium chloride injection, removes necrotic tissue.Control group Kangfuxin Liquid soak,
Daily dressing 2 times, keep the surface of a wound wet, until wound healing.Experimental group gives the Chinese medicine composition of the preparation of the embodiment of the present invention 1
Soak, daily dressing 2 times keep the surface of a wound wet, until wound healing.It is treated after 2 weeks according to the wound healing degree of patient
Effect evaluation.
3, observation of curative effect
3.1 criterions of therapeutical effect: " the disease of tcm Standardization of diagnosis and curative effect " promulgated referring to State Administration of Traditional Chinese Medicine determines.
It cures: decubitus ulcer healing；
Improve: decubitus ulcer area is obviously reduced；
Invalid: decubitus ulcer face is without improvement.
3.2 treatment results
It is as shown in table 1:
The treatment results of 1 the traditional chinese medicine composition of the invention of table
| Group | It cures | It is effective | In vain | It is efficient |
| Experimental group (22 people) | 18 | 4 | 0 | 100% |
| Control group (22 people) | 8 | 11 | 3 | 86.36% |
Experiment conclusion: the traditional chinese medicine composition of the invention for the ulcer wound surfaces such as bedsore, can be effectively controlled infection, swelling and pain relieving,
Wound healing, it is curative for effect, it is easy to use, it is worth clinical application.
To sum up, Chinese medicine composition energy myogenic hemostasis provided by the invention, swelling and pain relieving, more ulcer, especially for bedsore etc.
Ulcer wound surface has exact curative effect, and easy to use, has stronger practical application value.
Claims (10)
1. the Chinese medicine composition that ulcer is cured in a kind of myogenic hemostasia and detumescence analgesic, it is characterised in that: it is by the original of following weight proportion
Material medicine is prepared: 80~360 parts of the bletilla striata, 80~360 parts of olibanum, and 80~360 parts of myrrh, 80~360 parts of catechu, Chinese gall 80
~360 parts, 80~360 parts of the coptis, 80~360 parts of kuh-seng, 80~360 parts of Cortex Phellodendri, 40~180 parts of dragon's blood, Pollen Typhae 40~180
Part, 40~180 parts of Radix Notoginseng, 40~180 parts of the root of Dahurain angelica, 40~180 parts of Asian puccoon, raw 40~180 parts of Radix Astragali, 20~60 parts of Radix Angelicae Sinensis, ice
20~60 parts of piece, 20~60 parts of Radix Glycyrrhizae.
2. Chinese medicine composition according to claim 1, it is characterised in that: it is prepared by the bulk pharmaceutical chemicals of following weight proportion
It forms: 300 parts of the bletilla striata, 300 parts of olibanum, 300 parts of myrrh, 300 parts of catechu, 300 parts of Chinese gall, 300 parts of the coptis, 300 parts of kuh-seng,
300 parts of Cortex Phellodendri, 150 parts of dragon's blood, 150 parts of Pollen Typhae, 150 parts of Radix Notoginseng, 150 parts of the root of Dahurain angelica, 150 parts of Asian puccoon, raw 150 parts of Radix Astragali, when
Return 50 parts, 50 parts of borneol, 50 parts of Radix Glycyrrhizae.
3. Chinese medicine composition according to claim 1 or 2, it is characterised in that: it is by the bulk pharmaceutical chemicals of the weight proportion
Medicinal powder, bulk pharmaceutical chemicals water or extractive with organic solvent be active constituent, in addition what pharmaceutically acceptable auxiliary material was prepared
Preparation.
4. Chinese medicine composition according to claim 3, it is characterised in that: the preparation is external preparation.
5. Chinese medicine composition according to claim 4, it is characterised in that: the external preparation is lotion, plastics, puts on the skin
Agent, paste, decoction, powder, ointment, aerosol or spray.
6. a kind of method for preparing the described in any item Chinese medicine compositions of Claims 1 to 5, it is characterised in that: it includes as follows
Step:
A, the raw material of each weight proportion is weighed；
B, raw material directly beaten to powder, or after adding water or organic solvent to extract, be added pharmaceutically acceptable auxiliary material or it is complementary at
Divide and is prepared.
7. the described in any item Chinese medicine compositions of Claims 1 to 5 are preparing myogenic hemostasis, swelling and pain relieving, are being cured in the drug of ulcer
Purposes.
8. purposes according to claim 7, it is characterised in that: the drug is the drug of wound healing.
9. purposes according to claim 8, it is characterised in that: the surface of a wound is ulcer wound surface.
10. purposes according to claim 9, it is characterised in that: the ulcer wound surface is bedsore.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910164989.2A CN109674945A (en) | 2019-03-05 | 2019-03-05 | The Chinese medicine composition and preparation method thereof of ulcer is cured in a kind of myogenic hemostasia and detumescence analgesic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910164989.2A CN109674945A (en) | 2019-03-05 | 2019-03-05 | The Chinese medicine composition and preparation method thereof of ulcer is cured in a kind of myogenic hemostasia and detumescence analgesic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109674945A true CN109674945A (en) | 2019-04-26 |
Family
ID=66197638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910164989.2A Pending CN109674945A (en) | 2019-03-05 | 2019-03-05 | The Chinese medicine composition and preparation method thereof of ulcer is cured in a kind of myogenic hemostasia and detumescence analgesic |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109674945A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112870295A (en) * | 2021-03-22 | 2021-06-01 | 丽水市中心医院 | Traditional Chinese medicine granulation promoting powder and application thereof |
| CN113425797A (en) * | 2021-07-02 | 2021-09-24 | 昆明市第二人民医院 | Medicine and dressing for healing skin wound and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1548139A (en) * | 2003-05-19 | 2004-11-24 | 魏茂武 | Bedsore ointment and its prepn process |
| CN105535334A (en) * | 2016-02-20 | 2016-05-04 | 胶州市人民中医医院 | Radix arnebiae and milkvetch root granulation-promoting extract and preparation method |
| CN105535508A (en) * | 2016-01-28 | 2016-05-04 | 胶州市人民中医医院 | Radix astragali and sanguis draxonis bedsore healing unguent and preparation method |
-
2019
- 2019-03-05 CN CN201910164989.2A patent/CN109674945A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1548139A (en) * | 2003-05-19 | 2004-11-24 | 魏茂武 | Bedsore ointment and its prepn process |
| CN105535508A (en) * | 2016-01-28 | 2016-05-04 | 胶州市人民中医医院 | Radix astragali and sanguis draxonis bedsore healing unguent and preparation method |
| CN105535334A (en) * | 2016-02-20 | 2016-05-04 | 胶州市人民中医医院 | Radix arnebiae and milkvetch root granulation-promoting extract and preparation method |
Non-Patent Citations (1)
| Title |
|---|
| 石瑞梅: "自制中药制剂配合养疗治疗溃疡期压疮疗效观察", 《中国现代药物应用》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112870295A (en) * | 2021-03-22 | 2021-06-01 | 丽水市中心医院 | Traditional Chinese medicine granulation promoting powder and application thereof |
| CN113425797A (en) * | 2021-07-02 | 2021-09-24 | 昆明市第二人民医院 | Medicine and dressing for healing skin wound and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101167847B (en) | Traditional Chinese medicinal white spirit preparation for effectively treating skin disease | |
| CN105833279B (en) | External-use medicine composition for treating various wound surfaces of skin and preparation method thereof | |
| CN103463539A (en) | Drug for treating eczema, and preparation method and use thereof | |
| CN102228485B (en) | Composition for burn rehabilitation and preparation method thereof | |
| CN101961449B (en) | Traditional Chinese medicine for treating tinea corporis | |
| CN103784748B (en) | Medicine for treating diabetic foot disease and preparing method thereof | |
| CN109674945A (en) | The Chinese medicine composition and preparation method thereof of ulcer is cured in a kind of myogenic hemostasia and detumescence analgesic | |
| CN101703651A (en) | Medicament for treating diabetic gangrene | |
| CN102178811B (en) | Medicament for treating skin ulcer and preparation method thereof | |
| CN104383445A (en) | Traumatic injury analgesic | |
| CN102008576B (en) | External traditional Chinese medicine for treating sprain and preparation method thereof | |
| CN101879267B (en) | Compound tincture for treating foot helosis | |
| CN102716239A (en) | Pharmaceutical composite for treating traumatic injury | |
| CN102698086A (en) | Chinese medicinal emulsion for treating bedsore accumulated toxin decay | |
| CN108272960B (en) | Traditional Chinese medicine composition for treating hemorrhoidal disease and preparation method and application thereof | |
| CN105362437A (en) | Prescription of medical ointment for treating decubitus, and preparation method for medical ointment | |
| CN111544514A (en) | A Chinese medicinal ointment for treating burn and scald, and its preparation method | |
| CN109646512A (en) | A kind of external medicine composition for promoting chronic wound to heal | |
| CN109432262A (en) | A kind of Chinese medicine composition that treating gynaecological imflammation, preparation, preparation method and applications | |
| CN104248677A (en) | Traditional Chinese medicinal preparation for treating erythema multiforme | |
| CN113144018B (en) | Traditional Chinese medicine composition for treating blunt injury of soft tissues and extract and application thereof | |
| CN106943510A (en) | A kind of Chinese medicine composition of pre- counteracting bedsores and preparation method thereof | |
| CN105663753A (en) | Compound rhizoma coptidis ointment and method for preparing same | |
| CN101983681A (en) | Medicament for treating abnormal leucorrhea | |
| CN103356777B (en) | Medicament for treating rosacea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190426 |
|
| RJ01 | Rejection of invention patent application after publication |